Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00062504
Status:
TERMINATED
Last Update Posted:
2011-05-23
First Post:
2003-06-06
Brief Title:
Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
Sponsor:
Organization:
Teva Branded Pharmaceutical Products RD Inc